DUBLIN, April 23, 2013 /PRNewswire/ --
Research and Markets announces the addition of "Contrast Media/Contrast Agents Market by Product, by Technique & by Application - Global Trends & Forecast to 2017" to its catalogue.
Contrast Media/Contrast Agents Market by Product (Iodinated, Gadolinium & Barium), by Technique (X-ray, CT, MRI, Cath Lab & Ultrasound) & by Application (Radiology, Interventional Radiology & Interventional Cardiology) - Global Trends & Forecast to 2017.
Contrast agents have evolved significantly over the past century, from barium and iodine-based agents that were used initially by medical practitioners and radiologists, to the more advanced agents like radiopharmaceuticals and gold nanoparticles that are currently in use. Sophisticated techniques such as targeted MRI imaging and gas microbubble technology in ultrasound will prove to be essential drivers in the widespread use of contrast agents in the future.
The global contrast media market is broadly segmented into barium-based, iodinated and gadolinium-based contrast media. These products are further categorized based on the medical procedure (X-ray, CT, MRI, ultrasound, and catheterization laboratory), route of administration (oral, injection, rectal, and urethral), medical indication (cardiovascular, respiratory, musculoskeletal, gastrointestinal, and neurology, nephrology and oncology) and finally application (radiology, interventional radiology and interventional cardiology). The global contrast media market is worth $6.2 billion in 2012, and estimated to grow at a CAGR of 6.8% to reach $8.6 billion by 2017.
The global contrast media market, though fairly mature at present (2012), still shows potential to grow over the next five years. It is propelled by the increasing demand for diagnostic imaging and image guided surgical procedures, technological advances in diagnostic imaging and the ever-increasing incidence rates of cancer and cardiac disorders. However, a few pivotal factors affecting the growth of this market are major economies of the world undergoing healthcare reforms, thereby affecting contrast media sales and the economic slowdown restricting the overall growth of this market.
Key Topics Covered:
2 Executive Summary
3 Market Overview
4 Global Contrast Media Market, by Product
5 Global Contrast Media Market, by Route of Administration
6 Global Contrast Media Market, by Medical Procedure
7 Global Contrast Media Market, by Indication
8 Global Contrast Media Market, by Application
9 Geographic Analysis
10 Competitive Landscape
11 Company Profiles
- Amag Pharmaceuticals, Inc.
- Bayer Healthcare Pharmaceuticals
- Bracco Imaging Spa (A Subsidiary Of Bracco S.P.A)
- Cmc Contrast Ab
- Daiichi Sankyo Co., Ltd.
- Ge Healthcare
- Genovis Ab
- Guerbet Group
- Lantheus Medical Imaging, Inc.
- Nanopet Pharma Gmbh
- Nanoscan Imaging, Llc
- Sanochemia Pharmazeutika Ag
- Spago Imaging Ab (A Subsidiary Of Accelerator Nordic Ab)
- Subhra Pharma Private, Ltd
- Taejoon Pharm Co., Ltd.
- Targeson, Inc.
- Unijules Life Sciences, Ltd.
For more information please visit Research and Markets.
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Research and Markets
Laura Wood, Senior Manager.
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices
SOURCE Research and Markets